Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for MedWellAI (MWAI) over the last 12 years, with Q1 2025 value amounting to $5.9 million.

  • MedWellAI's Shares Outstanding (Weighted Average) rose 1742.81% to $5.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $5.9 million, marking a year-over-year increase of 1742.81%. This contributed to the annual value of $4.4 million for FY2024, which is 9643.18% up from last year.
  • As of Q1 2025, MedWellAI's Shares Outstanding (Weighted Average) stood at $5.9 million, which was up 1742.81% from $5.1 million recorded in Q3 2024.
  • Over the past 5 years, MedWellAI's Shares Outstanding (Weighted Average) peaked at $205.0 million during Q4 2021, and registered a low of $1.6 million during Q2 2022.
  • For the 5-year period, MedWellAI's Shares Outstanding (Weighted Average) averaged around $46.8 million, with its median value being $4.3 million (2023).
  • Per our database at Business Quant, MedWellAI's Shares Outstanding (Weighted Average) soared by 12333.74% in 2021 and then tumbled by 9911.83% in 2022.
  • Over the past 5 years, MedWellAI's Shares Outstanding (Weighted Average) (Quarter) stood at $205.0 million in 2021, then tumbled by 99.02% to $2.0 million in 2022, then soared by 111.37% to $4.2 million in 2023, then rose by 20.06% to $5.1 million in 2024, then increased by 17.14% to $5.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $5.9 million for Q1 2025, versus $5.1 million for Q3 2024 and $4.4 million for Q2 2024.